Marc Blaustein News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Finch Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Updates

SOMERVILLE, Mass., May 10, 2023 Finch Therapeutics Group, Inc. , a microbiome technology company with a portfolio of intellectual property and microbiome assets, today reported first quarter. | May 10, 2023

Matthew blischakStephen jasperMatthewp blischakDaphne moutsoglouLance thibaultMarc blausteinMark smithHercules capital incFinch therapeutics group incUniversity of minnesotaGilmartin groupExchange commissionCompany nasdaqTherapeutics groupChief executive officerClinical trial agreement

Finch Therapeutics Announces Executive Leadership Transitions

Finch Therapeutics Announces Executive Leadership Transitions
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

City ofUnited kingdomMark smithLance thibaultSusane grafMatthew blischakTom borodyMarc blausteinMatthewp blischakEli lillyAmerican university washington college of lawExchange commissionGiven the companyCompany nasdaqBentley universityFinch therapeutics group inc

The Top 25 Healthcare Technology Leaders of Massachusetts for 2023

New York, NY (PRWEB) February 15, 2023 The Healthcare Technology Report is pleased to announce The Top 25 Healthcare Technology Leaders of Massachusetts

New yorkUnited statesMeghan scanlonPaul gudonis myomoSlava akmaev scipherJean paul kress morphosysElizabeth haines conformisElizabeth hainesMark cobbold astrazenecaAndrew miller karunaJean paul kressGilmore oneill editasYaron rachmany variantyxPaul bolno wave life sciencesMarc blaustein finch therapeutics groupAntony mattessich ocular therapeutix inc

Finch Therapeutics Reports Fourth Quarter and Full Year

SOMERVILLE, Mass., March 31, 2022 (GLOBE NEWSWIRE) Finch Therapeutics Group, Inc. (“Finch” or “Finch Therapeutics”) (Nasdaq: FNCH), a clinical-stage.

Marc blausteinMark smithGreg perryAmerican college of gastroenterologyFinch therapeutics group incUlcerative colitis development program to takedaClinical developmentTherapeutics groupHuman first discoveryChief executive officerChief financial officerChief operating officerDigestive disease weekPositive topline resultsLabel trialWeek efficacy

Finch Therapeutics Announces the Appointment of Marc Blaustein as Chief Operating Officer

Finch Therapeutics Announces the Appointment of Marc Blaustein as Chief Operating Officer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Laurence wattsStephen jasperMark smithDrug administrationOperations at dyax corpGenetics instituteExchange commissionFinch therapeutics group incHarvard universityBerry company public relationsGilmartin groupUniversity of pennsylvaniaHead of business development for guide therapeuticsTherapeutics groupMarc blausteinChief operating